RxDoctor Payments Data

Bruce Tucker, MD

Internal Medicine · Santa Rosa, CANPI 1780677054

Payments from drug & device makers

$268in general payments, 2019–2025

Across 11 payments — averaging $24.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$49
  • Amgen$43
  • AbbVie$34
  • Viiv Healthcare Company$27
  • Gilead$24
  • Boston Scientific$23
  • plus $69 from 4 others

What the payments were for

  • Food & beverage$268100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$268 in reported general payments places this provider in the 55th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$354,787
Medicare patients
816
Services billed
4,823

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban170$190,561
XareltoRivaroxaban34$49,354
JardianceEmpagliflozin44$48,591
XifaxanRifaximin12$38,575
TrulicityDulaglutide21$26,939
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$26,698
Breo ElliptaFluticasone/Vilanterol20$16,554
OxycontinOxycodone Hcl11$15,661
JanuviaSitagliptin Phosphate13$15,150
OzempicSemaglutide12$10,669
Atorvastatin Calcium742$9,281
Levothyroxine Sodium498$7,014
Pantoprazole Sodium343$6,492
PremarinEstrogens, Conjugated17$5,875
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$5,599

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$20$196,436187 claims
AbbVieSynthroid$34$3,98153 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 13,581 internal medicine providers in California.

Other internal medicine in Santa Rosa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →